Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in INO held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.5M | $9.3M | -9.5% | 10.359% | 0.00% |
| 2 | Jupiter Topco LLC | 5.2M | $5.7M | β | 6.336% | 0.00% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | $4.0M | +25.8% | 4.473% | 0.00% |
| 4 | Boxer Capital Management, LLC | 2.8M | $3.1M | +20.0% | 3.486% | 0.24% |
| 5 | ADAR1 Capital Management, LLC | 2.1M | $2.4M | +45.8% | 2.627% | 0.11% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.6M | $1.7M | +242.6% | 1.934% | 0.00% |
| 7 | D. E. Shaw & Co., Inc. | 1.4M | $1.5M | -38.9% | 1.656% | 0.00% |
| 8 | TWO SIGMA INVESTMENTS, LP | 1.2M | $1.4M | +217.6% | 1.519% | 0.00% |
| 9 | Eversept Partners, LP | 1.0M | $1.1M | 0.0% | 1.268% | 0.06% |
| 10 | Caption Management, LLC | 879K | $967K | β | 1.077% | 0.00% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 803K | $884K | +0.2% | 0.984% | 0.00% |
| 12 | MILLENNIUM MANAGEMENT LLC | 796K | $876K | -43.6% | 0.975% | 0.00% |
| 13 | BlackRock, Inc. | 779K | $857K | +17.6% | 0.955% | 0.00% |
| 14 | CITADEL ADVISORS LLC | 645K | $710K | +53.0% | 0.791% | 0.00% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 481K | $529K | +22.6% | 0.589% | 0.00% |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 361K | $397K | -43.9% | 0.443% | 0.00% |
| 17 | STATE STREET CORP | 337K | $370K | +13.6% | 0.412% | 0.00% |
| 18 | TUDOR INVESTMENT CORP ET AL | 300K | $330K | β | 0.368% | 0.00% |
| 19 | DIADEMA PARTNERS LP | 275K | $303K | -56.9% | 0.337% | 0.04% |
| 20 | UBS Group AG | 262K | $289K | +5.1% | 0.321% | 0.00% |
| 21 | Quadrature Capital Ltd | 259K | $285K | β | 0.317% | 0.00% |
| 22 | JANE STREET GROUP, LLC | 190K | $209K | +129.1% | 0.233% | 0.00% |
| 23 | NORTHERN TRUST CORP | 174K | $192K | -41.6% | 0.214% | 0.00% |
| 24 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 173K | $190K | 0.0% | 0.212% | 0.00% |
| 25 | NOMURA HOLDINGS INC | 150K | $165K | β | 0.184% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in INO β a direct measure of their conviction.
Filings activity in INO during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | +5.9% | 43.90% | +4.65 pp | $39M | 29% |
| Q1 2026 | 101 | +0.0% | 39.25% | 2.08 pp | $55M | 4.4% |
| Q4 2025 | 101 | +3.1% | 41.33% | +15.49 pp | $58M | +20% |
| Q3 2025 | 98 | 5.8% | 25.84% | +1.68 pp | $48M | +134% |
| Q2 2025 | 104 | 4.6% | 24.16% | 7.56 pp | $21M | 6.4% |
| Q1 2025 | 109 | +4.8% | 31.72% | +0.17 pp | $22M | 10% |
| Q4 2024 | 104 | +6.1% | 31.55% | +20.66 pp | $24M | 52% |
| Q3 2024 | 98 | β | 10.89% | β | $51M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying INO stock.
Based on Q2 2026 13F filings, institutional ownership of Inovio Pharmaceuticals, Inc. stands at 43.9%, held across 107 reporting institutions.
FMR LLC is the largest reported institutional holder of INO, with approximately 8,454,797 shares worth $0.01B as of Q2 2026.
Yes β 6 widely-followed marquee investors appear among the top 25 institutional holders of INO, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for INO is 80 out of 100 (Strong Smart Money). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
21 institutions opened new positions in INO during Q2 2026, while 15 fully exited. 11 added to existing positions and 69 trimmed.
INO institutional ownership rose by 4.65 percentage points quarter-over-quarter, with a net change of +6 holders.
The top 10 institutions account for 80.1% of all reported 13F value in INO, and the top 25 account for 97.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Inovio Pharmaceuticals, Inc. (INO) Institutional Ownership